Home › Upcoming votes › Co-Diagnostics, Inc.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Co-Diagnostics, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Election of five directors Director election |
Board | For | — |
| 2 | Increase in shares under the 2025 Equity Incentive Plan | Board | For | — |
| 3 | Advisory vote on executive compensation Say on pay |
Board | For | — |
| 4 | Ratify Tanner LLC as auditor Auditor |
Board | For | — |
| 5 | Articles amendment to set one-third quorum | Board | For | — |
| 6 | Approve potential exercise of New Warrants (Nasdaq 5635(d)) | Board | For | — |
| 7 | Issuance of shares on conversion of secured convertible notes | Board | For | — |
| 8 | Reverse stock split amendment (up to 1-for-750) | Board | For | — |
| 9 | Adjournments or postponements of the Special Meeting Adjournment |
Board | For | — |
From Co-Diagnostics, Inc.’s Form 8-K, filed December 5, 2025, for the meeting held December 5, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. Proposal to approve an amendment to the Company's Articles of Incorporation to effect a reverse stock split of the Company's issued and o | 86% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.